Subscribe
cgore
26 June 2020Big PharmaRory O'Neill

LSPN Connect: MPP chief wants COVID-19 role

The executive director of the  Medicines Patent Pool (MPP) says it should have a role in fighting COVID-19, but it’s up to stakeholders to agree what that will be.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
LSPN Connect: micro-managing with Pendulum Therapeutics
6 August 2020   With any rapidly-developing field, particularly the life sciences, the importance of a coherent IP strategy cannot be ignored.
Americas
LSPN Connect: CRISPR, IP headaches and ‘deplorable’ diversity
31 July 2020   The development of CRISPR technology is showing no signs of losing momentum, and Arbor Biotechnologies is one company that is taking full advantage of this. We spoke to Kelly Morgan, senior director, head of IP and legal at the company to find out more.
Americas
US to pay Pfizer nearly $2bn for COVID-19 vaccine supply
23 July 2020   Pfizer and its German partner BioNTech will receive nearly $2 billion from the US in exchange for the supply of 100 million doses of an experimental coronavirus vaccine.


Editor's picks

BMS blocks biosimilar version of blockbuster cancer drug in India
Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025

Editor's picks

Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025
Africa
Explainer: ARIPO’s role in Plant Variety Protection
15 July 2025
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

More on this story

Biotechnology
LSPN Connect: micro-managing with Pendulum Therapeutics
6 August 2020   With any rapidly-developing field, particularly the life sciences, the importance of a coherent IP strategy cannot be ignored.
Americas
LSPN Connect: CRISPR, IP headaches and ‘deplorable’ diversity
31 July 2020   The development of CRISPR technology is showing no signs of losing momentum, and Arbor Biotechnologies is one company that is taking full advantage of this. We spoke to Kelly Morgan, senior director, head of IP and legal at the company to find out more.
Americas
US to pay Pfizer nearly $2bn for COVID-19 vaccine supply
23 July 2020   Pfizer and its German partner BioNTech will receive nearly $2 billion from the US in exchange for the supply of 100 million doses of an experimental coronavirus vaccine.

More on this story

Biotechnology
LSPN Connect: micro-managing with Pendulum Therapeutics
6 August 2020   With any rapidly-developing field, particularly the life sciences, the importance of a coherent IP strategy cannot be ignored.
Americas
LSPN Connect: CRISPR, IP headaches and ‘deplorable’ diversity
31 July 2020   The development of CRISPR technology is showing no signs of losing momentum, and Arbor Biotechnologies is one company that is taking full advantage of this. We spoke to Kelly Morgan, senior director, head of IP and legal at the company to find out more.
Americas
US to pay Pfizer nearly $2bn for COVID-19 vaccine supply
23 July 2020   Pfizer and its German partner BioNTech will receive nearly $2 billion from the US in exchange for the supply of 100 million doses of an experimental coronavirus vaccine.

More features

Could Apple v Masimo limit patent cases at the ITC?
Eli Lilly strikes again in weight-loss drugs fight
Novartis moves to block cancer drug generic in US
WATCH: China patent landscape—AI, patent linkage, export controls, and more
China bars USPTO employee from leaving country
UPC hands rare default win to Insulet, bans insulin pump in EU
GSK loses appeal over purple inhaler TM in Europe
Astellas defends Xtandi patent as court rejects generics’ appeal